Evaluating Biosimilar Real-World Evidence, Ongoing Trends, and Market Expansion in Rheumatology

Pricing: Free for Members and Non-Members

Course Description

Rheumatology biosimilars have had a historic number of biosimilar launches in 2023 and all eyes are focused on the current and upcoming pipeline and its available real-world evidence. This session will explore ongoing market and utilization trends and the complexities of biosimilar integration in the ever-evolving landscape of managed care.

Target Audience

Pharmacists who practice in managed care settings.

Learning Objectives

At the completion of this activity, participants should be able to:

  1. Review biosimilar complexities in rheumatology from a managed care perspective, including utilization trends and current regulatory standards.
  2. Identify evidence-based formulary considerations for the current biosimilar market, anticipated launches, and pipeline in rheumatology.
  3. Discuss available real-world evidence on the efficacy and safety of biosimilars in the rheumatology space to identify obstacles in the uptake of biosimilars and possible solutions.

Commercial Support

Supported by an independent education grant from Pfizer

Course summary
Available credit: 
  • 1.25 ACPE
    ACPE The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.25 Certificate of Completion
Course opens: 
05/03/2024
Course expires: 
12/31/2025
Cost:
$0.00

Faculty

Mark S. Box, MD

Physician
Carondelet Rheumatology
Kansas City, MO

Cassie Ramel, PharmD BCPS

Clinical Pharmacist
Mayo Clinic
Zumbrota, MN

Moderator

Amy Lugo, PharmD, BCPS, BC-ADM

CEO
LoneStar Health Solutions
San Antonio, Texas

 

Financial Relationship Disclosures

Faculty/Reviewer/PlannerReported Relevant Financial Relationships
Mark S. Box, MD
Faculty		Disclosed no relevant financial relationships.
Cassie Ramel, PharmD BCPS
Faculty		Disclosed no relevant financial relationships.

Casey Koch
Reviewer

Disclosed no relevant financial relationships.
Brooke Whittington
Planner		Disclosed no relevant financial relationships.
  • If applicable, relevant financial relationships have been mitigated and documented.
  • Content has undergone a peer review to ensure content validity.

Accreditation:

The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

ACPE UAN: 0233-0000-24-010-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: May 3, 2024 •  Expiration Date: December 31, 2025
Activity Fee: Free for Members and $30 for Non-Members

Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at AMCP 2024. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.

To receive credit for an online activity you must:

  • Review the full content of the activity.
  • Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
  • Complete a specific activity evaluation.

Available Credit

  • 1.25 ACPE
    ACPE The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
  • 1.25 Certificate of Completion

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

System Requirements Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating websites. View the minimum technical and system requirements for continuing education online learning activities